View Older Stories View More Recent Stories

Sep 21, 2015 08:00AM Pioneer Announces Proposed Public Offering of Common Stock

Sep 18, 2015 08:08AM Roth Capital Reiterates Buy on Daqo New Energy (DQ) Following Investor Meetings

Sep 17, 2015 05:58PM Intec Pharma Ltd. Announces Partial Exercise of Underwriters Option to Purchase Additional Ordinary Shares

Sep 17, 2015 11:15AM Sun Basket Announces $4.5 Million In Venture Funding Led by PivotNorth Capital and Baseline Ventures

Sep 17, 2015 09:34AM Roth Affirms TG Therapeutics (TGTX) at 'Focus Pick'; Ublituximab Combo SPA Validates Study Design

Sep 17, 2015 07:23AM Roth Capital Affirms Lion Bio (LBIO) at 'Buy' Following Positive TIL Phase 2 Data in Metastatic Melanoma

Sep 16, 2015 03:47PM Notable 52-Week Highs and Lows 9/16: (ITCI) (COLL) (UA) High; (GBSN) (XNPT) (NR) Low

Sep 16, 2015 12:38PM Roth Capital Downgrades Adept Technology (ADEP) to Neutral Amid Takeover

Sep 16, 2015 08:00AM Great Basin Announces Retention of Roth Capital Partners as Financial Advisor in Restructuring of the Company’s Series C Warrants

Sep 16, 2015 07:21AM Roth Capital Recommends Buying bluebird bio (BLUE) Into ASH

Sep 15, 2015 10:47AM The Sheckler Foundation's 8th Annual Celebrity Golf Tournament Raised $300,000 to Empower Those in Need

Sep 14, 2015 09:10AM Roth Capital Raises Price Target on Quicklogic Corp (QUIK) on Continuing Design Win Momentum

Sep 11, 2015 09:14AM Roth Keeps Cytori Therapeutics (CYTX) at 'Buy' Following Scleradec-I Trial Results; Data Bodes Well for Pivotal Program

Sep 11, 2015 09:01AM Roth Capital Reiterates Buy on Nektar Therapeutics (NKTR) After Meeting with Management

Sep 11, 2015 08:29AM Roth Reaffirms Applied Genetic (AGTC) at 'Buy' Following FY15 Results; Fundamental Thesis Remains Unchanged

Sep 11, 2015 07:45AM Roth Capital Starts Intec Pharma Ltd. (NTEC) at Buy

Sep 10, 2015 04:05PM GigOptix, Inc. Closes Public Offering of Common Stock to Support Enhanced Strategic Growth Through Acquisitions

Sep 10, 2015 09:00AM Roth Affirms Power Solutions (PSIX) at 'Buy' as Shares Retake Key Multiple Level

Sep 10, 2015 08:59AM Roth Capital Cuts Price Target on PriceSmart (PSMT) As Comps Hold in High-Single-Digits

Sep 9, 2015 10:54AM Roth Capital Reiterates Buy on Aduro Biotech (ADRO) Following Announced Incyte (INCY) Collaboration

Sep 9, 2015 10:35AM Notable Analyst Rating Changes 9/9: (GS) (CIEN) (WBA) Upgraded; (MNKD) (GOL) (MOBL) Downgraded

Sep 9, 2015 08:41AM Roth Capital Downgrades Quiksilver (ZQK) to Sell

Sep 9, 2015 08:05AM Roth Capital reiterated remains Bullish on Roth Capital Sequential Brands (SQBG) Following signed Licensing Agreement

Sep 9, 2015 07:23AM Roth Capital Downgrades Yingli Green Energy (YGE) to Sell

Sep 8, 2015 09:00AM Sphere 3D to Participate at ROTH Datacenter Technology Corporate Access Day in San Francisco on September 9, 2015

Sep 8, 2015 07:50AM Roth Capital Remains Bullish on Plantronics (PLT) Following Investor Day

Sep 8, 2015 06:54AM Roth Capital Sees Attractive Risk/Reward for uniQure (QURE) Into Sanfilippo Abstract

Sep 4, 2015 05:49PM InSite Vision Determines that an Unsolicited Offer from a Global Pharmaceutical Company to Acquire InSite for $0.35 per Share in Cash Constitutes a “Company Superior Proposal”

Sep 3, 2015 04:12PM InSite Vision Receives Second Unsolicited Acquisition Proposal for $0.35 per Share From a Global Pharmaceutical Company

Sep 3, 2015 12:05PM BIO Announces Presenting Companies for 14th Annual BIO Investor Forum

Sep 3, 2015 09:32AM Roth Capital Affirms Sarepta (SRPT) at 'Buy'; Shapeshifting Bears Back to Where It Started

Sep 3, 2015 09:02AM Roth Capital Reiterates Buy on Performance Sports Group (PSG) Following Analyst and Investor Event

Sep 3, 2015 08:18AM Roth Capital Raises Price Target on Lannett (LCI) Following Acquisition of Kremers Urban Pharmaceuticals

Sep 2, 2015 04:30PM Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion

Sep 2, 2015 11:28AM ROTH Capital Partners to Host Solar Symposium at Solar Power International (SPI 15)

Sep 2, 2015 09:05AM Roth Capital Reiterates Buy on Ligand Pharma (LGND) Following E.U. Approval of Promacta

Sep 2, 2015 08:38AM Ligand Pharma (LGND) Reaffirmed at 'Buy' by Roth Following European Promacta Approval, Evomela Update

Sep 2, 2015 08:26AM Roth Capital Cuts Price Target on Crossroads Systems (CRDS) Ahead of 3Q Results

Sep 2, 2015 08:00AM InterCloud Systems to Present at the 4th Annual Liolios Gateway Conference on September 9, 2015

Sep 1, 2015 09:41AM Roth Capital Reiterates Buy on Trevena (TRVN) Following TRV130’s Phase 2b Results

Sep 1, 2015 08:40AM Roth Capital Positive on SolarEdge (SEDG) Following Recent Investor Meetings

Sep 1, 2015 06:40AM Roth Updates Ests on Adept Technology (ADEP) Following Q4 Results, Outlook; Maintains 'Buy' Rating

Aug 28, 2015 12:07PM Streetinsider.com's Hot Lunchtime Reads 8/28: (GME) (GB) (FXI) (ADP)

Aug 28, 2015 11:45AM Roth Capital Trims Ests on Sky Solar (SKYS) Following Q2 Results; Sees Close to Securing Capital

Aug 28, 2015 08:31AM 4th Annual Liolios Gateway Conference to Showcase More Than 90 Growth Companies in San Francisco on September 9-10

Aug 28, 2015 07:45AM Roth Capital Re-Starts RMG Networks Holding (RMGN) at Buy

Aug 28, 2015 07:42AM Roth Capital Starts Cerulean Pharma (CERU) at Buy, $9 PT

Aug 27, 2015 09:46AM Applied Genetic Tech (AGTC) Triggers Enrollment Milestone in XLRS Phase I/II; Roth Affirms at 'Buy'

Aug 27, 2015 07:08AM Roth Capital Cuts Price target on Tilly's, Inc. (TLYS) to $12 Following EPS Beat

Aug 26, 2015 04:05PM GigOptix, Inc. Closes Public Offering of Common Stock to Support Enhanced Strategic Growth Through Acquisitions

View More Recent Stories View Older Stories